 Phase: Phase IIType: TreatmentStatus: ActiveAge: Over 18 to 80Sponsor: OtherProtocol IDs: P130944, 2014-001741-24, NCT02212639Phase: Phase IType: BiomarkerLaboratory analysis, TreatmentStatus: Approved-not yet activeAge: 19 and overSponsor: NCIProtocol IDs: NCI-2015-00461, AMC-095, U01CA121947, NCT02408861 